{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:47:15Z","timestamp":1792666035686,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T00:00:00Z","timestamp":1554336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T00:00:00Z","timestamp":1554336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The tumor microenvironment can be spatially heterogenous, which makes it challenging to fully characterize with standard 2D histology-based methods. In this study, we determined the feasibility of a CLARITY tissue-processing approach to analyze biopsies from breast cancer patients. Formalin-fixed human breast cancer core-needle biopsy specimens, were embedded, lipid-cleared, and multiplexed immunostained to identify key biomarkers (pan-cytokeratin, Ki67, CD3). Confocal microscopy was then used to image the specimens after refractive index matching. These data sets were then quantitatively compared to conventional slide-based FFPE histology. Using CLARITY, the gross and cellular morphology of the tissues were well preserved, and high optical transparency was achieved, with the exception of fibrotic regions. Specific staining of various cellular and nuclear markers was achieved using optimized antibody conditions. Manually determined composite Ki67 scores from the CLARITY datasets agreed with histology results. However, the CLARITY datasets (3D) revealed variation in the intra-tumoral Ki67 expression that was not evident in individual FFPE sections (2D). We further demonstrated that archived FFPE clinical specimens can be CLARITY-processed, immunostained, and imaged. In short, CLARITY-processed specimens may enable a more accurate, unbiased analysis of tumor samples in comparison to conventional slide-based histology, thus allowing for improved visualization of intra-tumoral heterogeneity.<\/jats:p>","DOI":"10.1038\/s41598-019-41957-w","type":"journal-article","created":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T10:04:10Z","timestamp":1554372250000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Three-dimensional imaging and quantitative analysis in CLARITY processed breast cancer tissues"],"prefix":"10.1038","volume":"9","author":[{"given":"Yi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharla L.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yesim","family":"Gokmen-Polar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8861-9980","authenticated-orcid":false,"given":"Sunil","family":"Badve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie J.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,4]]},"reference":[{"key":"41957_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-015-0278-7","volume":"13","author":"F Chen","year":"2015","unstructured":"Chen, F. et al. New horizons in tumor microenvironment biology: challenges and opportunities. BMC Med 13, 45, https:\/\/doi.org\/10.1186\/s12916-015-0278-7 (2015).","journal-title":"BMC Med"},{"key":"41957_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40425-016-0107-3","volume":"4","author":"J Yuan","year":"2016","unstructured":"Yuan, J. et al. Novel technologies and emerging biomarkers for personalized cancer immunotherapy. J Immunother Cancer 4, 3, https:\/\/doi.org\/10.1186\/s40425-016-0107-3 (2016).","journal-title":"J Immunother Cancer"},{"key":"41957_CR3","doi-asserted-by":"publisher","unstructured":"Feng, Z. et al. Multiparametric immune profiling in HPV- oral squamous cell cancer. JCI Insight 2, https:\/\/doi.org\/10.1172\/jci.insight.93652 (2017).","DOI":"10.1172\/jci.insight.93652"},{"key":"41957_CR4","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/bjc.2017.171","volume":"117","author":"K Cyll","year":"2017","unstructured":"Cyll, K. et al. Tumour heterogeneity poses a significant challenge to cancer biomarker research. Br J Cancer 117, 367\u2013375, https:\/\/doi.org\/10.1038\/bjc.2017.171 (2017).","journal-title":"Br J Cancer"},{"key":"41957_CR5","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/modpathol.2016.213","volume":"30","author":"TJ Gniadek","year":"2017","unstructured":"Gniadek, T. J. et al. Heterogeneous expression of PD-L1 in pulmonary squamous cell carcinoma and adenocarcinoma: implications for assessment by small biopsy. Mod Pathol 30, 530\u2013538, https:\/\/doi.org\/10.1038\/modpathol.2016.213 (2017).","journal-title":"Mod Pathol"},{"key":"41957_CR6","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3389\/fmed.2018.00085","volume":"5","author":"G Stanta","year":"2018","unstructured":"Stanta, G. & Bonin, S. Overview on Clinical Relevance of Intra-Tumor Heterogeneity. Front Med (Lausanne) 5, 85, https:\/\/doi.org\/10.3389\/fmed.2018.00085 (2018).","journal-title":"Front Med (Lausanne)"},{"key":"41957_CR7","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3389\/fmed.2017.00227","volume":"4","author":"G Turashvili","year":"2017","unstructured":"Turashvili, G. & Brogi, E. Tumor Heterogeneity in Breast Cancer. Front Med (Lausanne) 4, 227, https:\/\/doi.org\/10.3389\/fmed.2017.00227 (2017).","journal-title":"Front Med (Lausanne)"},{"key":"41957_CR8","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/nature12107","volume":"497","author":"K Chung","year":"2013","unstructured":"Chung, K. et al. Structural and molecular interrogation of intact biological systems. Nature 497, 332\u2013337, https:\/\/doi.org\/10.1038\/nature12107 (2013).","journal-title":"Nature"},{"key":"41957_CR9","doi-asserted-by":"publisher","unstructured":"Epp, J. R. et al. Optimization of CLARITY for Clearing Whole-Brain and Other Intact Organs. eNeuro 2, https:\/\/doi.org\/10.1523\/ENEURO.0022-15.2015 (2015).","DOI":"10.1523\/ENEURO.0022-15.2015"},{"key":"41957_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-05614-4","volume":"7","author":"B Hsueh","year":"2017","unstructured":"Hsueh, B. et al. Pathways to clinical CLARITY: volumetric analysis of irregular, soft, and heterogeneous tissues in development and disease. Sci Rep 7, 5899, https:\/\/doi.org\/10.1038\/s41598-017-05614-4 (2017).","journal-title":"Sci Rep"},{"key":"41957_CR11","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.cell.2016.01.038","volume":"164","author":"EL Sylwestrak","year":"2016","unstructured":"Sylwestrak, E. L., Rajasethupathy, P., Wright, M. A., Jaffe, A. & Deisseroth, K. Multiplexed Intact-Tissue Transcriptional Analysis at Cellular Resolution. Cell 164, 792\u2013804, https:\/\/doi.org\/10.1016\/j.cell.2016.01.038 (2016).","journal-title":"Cell"},{"key":"41957_CR12","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1038\/nprot.2014.123","volume":"9","author":"R Tomer","year":"2014","unstructured":"Tomer, R., Ye, L., Hsueh, B. & Deisseroth, K. Advanced CLARITY for rapid and high-resolution imaging of intact tissues. Nat Protoc 9, 1682\u20131697, https:\/\/doi.org\/10.1038\/nprot.2014.123 (2014).","journal-title":"Nat Protoc"},{"key":"41957_CR13","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1146\/annurev-cellbio-111315-125001","volume":"32","author":"K Tainaka","year":"2016","unstructured":"Tainaka, K., Kuno, A., Kubota, S. I., Murakami, T. & Ueda, H. R. Chemical Principles in Tissue Clearing and Staining Protocols for Whole-Body Cell Profiling. Annu Rev Cell Dev Biol 32, 713\u2013741, https:\/\/doi.org\/10.1146\/annurev-cellbio-111315-125001 (2016).","journal-title":"Annu Rev Cell Dev Biol"},{"key":"41957_CR14","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.cell.2015.06.067","volume":"162","author":"DS Richardson","year":"2015","unstructured":"Richardson, D. S. & Lichtman, J. W. Clarifying Tissue Clearing. Cell 162, 246\u2013257, https:\/\/doi.org\/10.1016\/j.cell.2015.06.067 (2015).","journal-title":"Cell"},{"key":"41957_CR15","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/nmeth.2481","volume":"10","author":"K Chung","year":"2013","unstructured":"Chung, K. & Deisseroth, K. CLARITY for mapping the nervous system. Nat Methods 10, 508\u2013513, https:\/\/doi.org\/10.1038\/nmeth.2481 (2013).","journal-title":"Nat Methods"},{"key":"41957_CR16","doi-asserted-by":"publisher","first-page":"e10032","DOI":"10.7554\/eLife.10032","volume":"4","author":"W Menegas","year":"2015","unstructured":"Menegas, W. et al. Dopamine neurons projecting to the posterior striatum form an anatomically distinct subclass. Elife 4, e10032, https:\/\/doi.org\/10.7554\/eLife.10032 (2015).","journal-title":"Elife"},{"key":"41957_CR17","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1016\/j.cell.2016.05.010","volume":"165","author":"L Ye","year":"2016","unstructured":"Ye, L. et al. Wiring and Molecular Features of Prefrontal Ensembles Representing Distinct Experiences. Cell 165, 1776\u20131788, https:\/\/doi.org\/10.1016\/j.cell.2016.05.010 (2016).","journal-title":"Cell"},{"key":"41957_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/srep09808","volume":"5","author":"I Costantini","year":"2015","unstructured":"Costantini, I. et al. A versatile clearing agent for multi-modal brain imaging. Sci Rep 5, 9808, https:\/\/doi.org\/10.1038\/srep09808 (2015).","journal-title":"Sci Rep"},{"key":"41957_CR19","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s00401-014-1322-y","volume":"128","author":"K Ando","year":"2014","unstructured":"Ando, K. et al. Inside Alzheimer brain with CLARITY: senile plaques, neurofibrillary tangles and axons in 3-D. Acta Neuropathol 128, 457\u2013459, https:\/\/doi.org\/10.1007\/s00401-014-1322-y (2014).","journal-title":"Acta Neuropathol"},{"key":"41957_CR20","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s10456-017-9565-6","volume":"20","author":"T Lagerweij","year":"2017","unstructured":"Lagerweij, T. et al. Optical clearing and fluorescence deep-tissue imaging for 3D quantitative analysis of the brain tumor microenvironment. Angiogenesis 20, 533\u2013546, https:\/\/doi.org\/10.1007\/s10456-017-9565-6 (2017).","journal-title":"Angiogenesis"},{"key":"41957_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-016-0754-9","volume":"18","author":"B Lloyd-Lewis","year":"2016","unstructured":"Lloyd-Lewis, B. et al. Imaging the mammary gland and mammary tumours in 3D: optical tissue clearing and immunofluorescence methods. Breast Cancer Res 18, 127, https:\/\/doi.org\/10.1186\/s13058-016-0754-9 (2016).","journal-title":"Breast Cancer Res"},{"key":"41957_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/srep18631","volume":"6","author":"E Lee","year":"2016","unstructured":"Lee, E. et al. ACT-PRESTO: Rapid and consistent tissue clearing and labeling method for 3-dimensional (3D) imaging. Sci Rep 6, 18631, https:\/\/doi.org\/10.1038\/srep18631 (2016).","journal-title":"Sci Rep"},{"key":"41957_CR23","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12861-014-0048-3","volume":"14","author":"H Lee","year":"2014","unstructured":"Lee, H., Park, J. H., Seo, I., Park, S. H. & Kim, S. Improved application of the electrophoretic tissue clearing technology, CLARITY, to intact solid organs including brain, pancreas, liver, kidney, lung, and intestine. BMC Dev Biol 14, 48, https:\/\/doi.org\/10.1186\/s12861-014-0048-3 (2014).","journal-title":"BMC Dev Biol"},{"key":"41957_CR24","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.cell.2014.07.017","volume":"158","author":"B Yang","year":"2014","unstructured":"Yang, B. et al. Single-cell phenotyping within transparent intact tissue through whole-body clearing. Cell 158, 945\u2013958, https:\/\/doi.org\/10.1016\/j.cell.2014.07.017 (2014).","journal-title":"Cell"},{"key":"41957_CR25","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s00429-017-1583-z","volume":"223","author":"DM Krolewski","year":"2018","unstructured":"Krolewski, D. M. et al. Quantitative validation of immunofluorescence and lectin staining using reduced CLARITY acrylamide formulations. Brain Struct Funct 223, 987\u2013999, https:\/\/doi.org\/10.1007\/s00429-017-1583-z (2018).","journal-title":"Brain Struct Funct"},{"key":"41957_CR26","doi-asserted-by":"publisher","first-page":"5915","DOI":"10.1158\/1538-7445.AM2017-5915","volume":"77","author":"SL White","year":"2017","unstructured":"White, S. L., McCurdy, S. & Goodman, L. J. Three-dimensional, 3-D, multiplex imaging of biomarkers in tumor tissue. Cancer Res 77, 5915\u20135915, https:\/\/doi.org\/10.1158\/1538-7445.AM2017-5915 (2017).","journal-title":"Cancer Res"},{"key":"41957_CR27","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1634\/theoncologist.2016-0352","volume":"22","author":"YJ Shi","year":"2017","unstructured":"Shi, Y. J., Tsang, J. Y., Ni, Y. B. & Tse, G. M. Intratumoral Heterogeneity in Breast Cancer: A Comparison of Primary and Metastatic Breast Cancers. Oncologist 22, 487\u2013490, https:\/\/doi.org\/10.1634\/theoncologist.2016-0352 (2017).","journal-title":"Oncologist"},{"key":"41957_CR28","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1093\/jnci\/djr393","volume":"103","author":"M Dowsett","year":"2011","unstructured":"Dowsett, M. et al. Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group. J Natl Cancer Inst 103, 1656\u20131664, https:\/\/doi.org\/10.1093\/jnci\/djr393 (2011).","journal-title":"J Natl Cancer Inst"},{"key":"41957_CR29","doi-asserted-by":"publisher","first-page":"e0172031","DOI":"10.1371\/journal.pone.0172031","volume":"12","author":"MH Jang","year":"2017","unstructured":"Jang, M. H., Kim, H. J., Chung, Y. R., Lee, Y. & Park, S. Y. A comparison of Ki-67 counting methods in luminal Breast Cancer: The Average Method vs. the Hot Spot Method. PLoS One 12, e0172031, https:\/\/doi.org\/10.1371\/journal.pone.0172031 (2017).","journal-title":"PLoS One"},{"key":"41957_CR30","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1111\/ijlh.12068","volume":"35","author":"BD Hedley","year":"2013","unstructured":"Hedley, B. D. & Keeney, M. Technical issues: flow cytometry and rare event analysis. Int J Lab Hematol 35, 344\u2013350, https:\/\/doi.org\/10.1111\/ijlh.12068 (2013).","journal-title":"Int J Lab Hematol"},{"key":"41957_CR31","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.5858\/arpa.2013-0691-RA","volume":"138","author":"BP Bass","year":"2014","unstructured":"Bass, B. P., Engel, K. B., Greytak, S. R. & Moore, H. M. A review of preanalytical factors affecting molecular, protein, and morphological analysis of formalin-fixed, paraffin-embedded (FFPE) tissue: how well do you know your FFPE specimen? Arch Pathol Lab Med 138, 1520\u20131530, https:\/\/doi.org\/10.5858\/arpa.2013-0691-RA (2014).","journal-title":"Arch Pathol Lab Med"},{"key":"41957_CR32","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.anndiagpath.2010.02.001","volume":"14","author":"RJ Buesa","year":"2010","unstructured":"Buesa, R. J. Staffing benchmarks for histology laboratories. Ann Diagn Pathol 14, 182\u2013193, https:\/\/doi.org\/10.1016\/j.anndiagpath.2010.02.001 (2010).","journal-title":"Ann Diagn Pathol"},{"key":"41957_CR33","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1369\/0022155417719419","volume":"65","author":"MM Bolognesi","year":"2017","unstructured":"Bolognesi, M. M. et al. Multiplex Staining by Sequential Immunostaining and Antibody Removal on Routine Tissue Sections. J Histochem Cytochem 65, 431\u2013444, https:\/\/doi.org\/10.1369\/0022155417719419 (2017).","journal-title":"J Histochem Cytochem"},{"key":"41957_CR34","doi-asserted-by":"publisher","unstructured":"Rimm, D. L. et al. A Prospective, Multi-institutional, Pathologist-Based Assessment of 4 Immunohistochemistry Assays for PD-L1 Expression in Non-Small Cell Lung Cancer. JAMA O\n                           ncol, https:\/\/doi.org\/10.1001\/jamaoncol.2017.0013 (2017).","DOI":"10.1001\/jamaoncol.2017.0013"},{"key":"41957_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-016-0925-6","volume":"14","author":"WY Sun","year":"2016","unstructured":"Sun, W. Y., Lee, Y. K. & Koo, J. S. Expression of PD-L1 in triple-negative breast cancer based on different immunohistochemical antibodies. J Transl Med 14, 173, https:\/\/doi.org\/10.1186\/s12967-016-0925-6 (2016).","journal-title":"J Transl Med"},{"key":"41957_CR36","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40425-016-0115-3","volume":"4","author":"EC Stack","year":"2016","unstructured":"Stack, E. C., Foukas, P. G. & Lee, P. P. Multiplexed tissue biomarker imaging. J Immunother Cancer 4, 9, https:\/\/doi.org\/10.1186\/s40425-016-0115-3 (2016).","journal-title":"J Immunother Cancer"},{"key":"41957_CR37","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/modpathol.2017.143","volume":"31","author":"MJ Gerdes","year":"2018","unstructured":"Gerdes, M. J. et al. Single-cell heterogeneity in ductal carcinoma in situ of breast. Mod Pathol 31, 406\u2013417, https:\/\/doi.org\/10.1038\/modpathol.2017.143 (2018).","journal-title":"Mod Pathol"},{"key":"41957_CR38","doi-asserted-by":"publisher","first-page":"E6274","DOI":"10.1073\/pnas.1510133112","volume":"112","author":"SY Kim","year":"2015","unstructured":"Kim, S. Y. et al. Stochastic electrotransport selectively enhances the transport of highly electromobile molecules. Proc Natl Acad Sci USA 112, E6274\u20136283, https:\/\/doi.org\/10.1073\/pnas.1510133112 (2015).","journal-title":"Proc Natl Acad Sci USA"},{"key":"41957_CR39","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.5858\/arpa.2016-0386-RA","volume":"141","author":"F Aeffner","year":"2017","unstructured":"Aeffner, F. et al. The Gold Standard Paradox in Digital Image Analysis: Manual Versus Automated Scoring as Ground Truth. Arch Pathol Lab Med 141, 1267\u20131275, https:\/\/doi.org\/10.5858\/arpa.2016-0386-RA (2017).","journal-title":"Arch Pathol Lab Med"},{"key":"41957_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-016-0623-5","volume":"14","author":"S Farkona","year":"2016","unstructured":"Farkona, S., Diamandis, E. P. & Blasutig, I. M. Cancer immunotherapy: the beginning of the end of cancer? BMC Med 14, 73, https:\/\/doi.org\/10.1186\/s12916-016-0623-5 (2016).","journal-title":"BMC Med"},{"key":"41957_CR41","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s12022-015-9379-2","volume":"26","author":"TN Kroneman","year":"2015","unstructured":"Kroneman, T. N. et al. Comparison of Three Ki-67 Index Quantification Methods and Clinical Significance in Pancreatic Neuroendocrine Tumors. Endocr Pathol 26, 255\u2013262, https:\/\/doi.org\/10.1007\/s12022-015-9379-2 (2015).","journal-title":"Endocr Pathol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-41957-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-41957-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-41957-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T08:23:58Z","timestamp":1671265438000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-41957-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,4]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["41957"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-41957-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,4]]},"assertion":[{"value":"8 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"L.G., Y.C., Q.S. and S.W. have received compensation as employees of ClearLight Biotechnologies, L.L.C., S.B. serves as scientific advisor for ClearLight Biotechnologies, L.L.C., but received no compensation. Y.G.-P. declared no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"5624"}}